15-Day Duration of Venetoclax Combined with Azacitidine in Treatment-Naive Higher-Risk Myelodysplastic Syndromes: A Prospective Multicenter Study
维奈托克联合阿扎胞苷治疗初治高危骨髓增生异常综合征15天:一项前瞻性多中心研究
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18010159
Lai, Binbin; Mei, Chen; Yan, Xiao; Chen, Lieguang; Wang, Yi; Sheng, Lixia; Tang, Shanhao; Mao, Liping; Zhang, Ping; Sun, Yongcheng; Xie, Wanzhuo; Zhou, De; Mai, Wenyuan; Wang, Huafeng; Ma, Liya; Lou, Yinjun; Wu, Wenjun; Jiang, Huifang; Zhang, Jin; Ye, Baodong; Tong, Hongyan; Ouyang, Guifang